Biotech Immunogen showed signs of life today after getting FDA approval of a new breast cancer treatment. Cramer talks to CEO Daniel Junius about the progress of the drug and when patients will see it in doctor's offices, as well as what it means to the company.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT